Status:
COMPLETED
Heart Failure Medication Adherence
Lead Sponsor:
University of Miami
Collaborating Sponsors:
Beta Tau Chapter of Sigma Theta Tau International
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this investigation is to pilot test a medication in-hand intervention (Meds to Beds) compared to standard care for patients with heart failure (ICD-50\[all numbers\]). The study will ...
Eligibility Criteria
Inclusion
- Admission diagnosis of heart failure ICD-50, including I50.1, I50.2, I50.20, I50.21, I50.22, I50.23, I50.3, I50.30, I50.31, I50.32, I50.33, I50.4, I50.40, I50.41, I50.42, I50.43, I50.8, I50.81, I50.810, I50.811, I50.812, I50.813, I50.814, I50.82, I50.83, I50.84, I50.89, I50.9, or any combination thereof
- Age 18 or older
- New York Heart Association Heart Failure Class II or Class III, with ejection fraction below 45%
- Cognitively intact, without significant psychological impairment affecting medication adherence such as dementia noted in patient record.
Exclusion
- Medical conditions, such as active cancer or pregnancy, expected to alter heart failure medication management
- Discharged to nursing homes or hospice care, where patient may not responsible for their own adherence
- High risk of loss to follow-up, e.g., leaving the hospital against medical advice, prisoners, living in a homeless shelter, or unable to provide a phone number
- No plan to fill medications at the Jackson Memorial Hospital pharmacy
Key Trial Info
Start Date :
May 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 8 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03402750
Start Date
May 28 2018
End Date
April 8 2019
Last Update
November 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jackson Memorial Hospital
Miami, Florida, United States, 33136